Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:14 PM
Ignite Modification Date:
2025-12-24 @ 10:14 PM
NCT ID:
NCT04960735
Eligibility Criteria:
Inclusion Criteria for patients with breast cancer:
* male and female over 18
* recently diagnosed with invasive stage I-IV cancer, or Ductal Carcinoma in Situ (DCIS)
* undergoing any treatment type (surgery, radiotherapy, chemotherapy, hormone therapy and/or targeted therapy).
Inclusion Criteria for patients with lung cancer:
* male and female over 18
* newly diagnosed with lung cancer
* eligible to receive curative or palliative care treatment.
Exclusion Criteria for patients with breast cancer:
* With rare tumours
* With Lobular Carcinoma In Situ (LCIS)
* With recurring illness
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04960735
Study Brief:
Protocol Section:
NCT04960735